Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer&#39;s disease

Código QR

Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer&#39;s disease

Manal Fouad Ismail,1 Aliaa Nabil ElMeshad,2 Neveen Abdel-Hameed Salem31Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt; 2Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt; 3Department of Narcotics and Ergogenic Ai...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ismail MF, ElMeshad AN, Salem NA
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/0a5cad646838461589e4243bc5515cea
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Rivastigmine in the treatment of Alzheimer's disease: an update
por: Maria Luisa Onor, et al.
Publicado: (2007)

Domperidone effective in preventing rivastigmine-related gastrointestinal disturbances in patients with Alzheimer's disease
por: Kano O, et al.
Publicado: (2013)

Two cases of Alzheimer&#39;s disease showing deterioration of behavioral and psychological symptoms of dementia induced by switching from rivastigmine to donepezil
por: Kimura T, et al.
Publicado: (2012)

Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer&rsquo;s disease in daily practice
por: Seibert J, et al.
Publicado: (2012)

Rivastigmine for the treatment of dementia associated with Parkinson&rsquo;s disease
por: Jennifer L Reingold, et al.
Publicado: (2007)

Alzheimer&#39;s disease and primary open-angle glaucoma: is there a connection
por: Tsolaki F, et al.
Publicado: (2011)

The Potential Effect of Insulin on AChE and Its Interactions with Rivastigmine In Vitro
por: Tahereh Jamshidnejad-Tosaramandani, et al.
Publicado: (2021)

Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer&#39;s disease in the Netherlands
por: Hoogveldt B, et al.
Publicado: (2011)

Potential sources of stem cells as a regenerative therapy for Parkinson&#39;s disease
por: Abir Oueida El-Sadik
Publicado: (2010)

Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis
por: Richard A Hansen, et al.
Publicado: (2008)

The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na+,&nbsp;K+)-, Mg2+-ATPase activities, antioxidant status, and learning performance of aged rats
por: Haris Carageorgiou, et al.
Publicado: (2008)

The genetics of Alzheimer's disease
por: Bagyinszky E, et al.
Publicado: (2014)

Rivastigmine in Chinese patients with subcortical vascular dementia
por: Vincent Mok, et al.
Publicado: (2007)

Editor&#39;s choice
por: Pinder RM
Publicado: (2012)

A review of the potential therapeutic role of statins in the treatment of Alzheimer&rsquo;s disease: current research and opinion
por: Mitchell AJ, et al.
Publicado: (2013)

Green Synthesized Honokiol Transfersomes Relieve the Immunosuppressive and Stem-Like Cell Characteristics of the Aggressive B16F10 Melanoma
por: Ezzeldeen Y, et al.
Publicado: (2021)

Alzheimer's disease and blood-based biomarkers – potential contexts of use
por: Zvěřová M
Publicado: (2018)

Present and prospective clinical therapeutic regimens for Alzheimer&rsquo;s disease
por: Mustafa M Husain, et al.
Publicado: (2008)

Galantamine treatment in Alzheimer&#39;s disease: response and long-term outcome in a routine clinical setting
por: Wallin &Aring;K, et al.
Publicado: (2011)

Minimally invasive biomarker confirms glial activation present in Alzheimer&#39;s disease: a preliminary study
por: Tran T, et al.
Publicado: (2011)

Neovascularization in Purtscher&#39;s retinopathy
por: Chan A, et al.
Publicado: (2011)

Decreased white matter integrity before the onset of delusions in patients with Alzheimer&#39;s disease: diffusion tensor imaging
por: Nakaaki S, et al.
Publicado: (2012)

Long noncoding RNAs and Alzheimer's disease
por: Luo Q, et al.
Publicado: (2016)

The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study
por: Yatawara C, et al.
Publicado: (2021)

Review: management of Parkinson&#39;s disease
por: Pedrosa DJ, et al.
Publicado: (2013)

Zein/Phospholipid Composite Nanoparticles for Successful Delivery of Gallic Acid into aHSCs: Influence of Size, Surface Charge, and Vitamin A Coupling
por: Radwan SAA, et al.
Publicado: (2020)

Rehabilitating a brain with Alzheimer's: a proposal
por: Gonzalo Emiliano Aranda-Abreu, et al.
Publicado: (2011)

Descemet&#39;s stripping automated endothelial keratoplasty for congenital hereditary endothelial dystrophy
por: Anwar HM, et al.
Publicado: (2012)

Genes associated with Alzheimer's disease: an overview and current status
por: Giri M, et al.
Publicado: (2016)

Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors
por: Ferris SH, et al.
Publicado: (2013)

Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
por: Qinqin Wang, et al.
Publicado: (2021)

Adjunctive therapy in Parkinson&#39;s disease: the role of rasagiline
por: Gaines KD, et al.
Publicado: (2012)

Potential therapeutic effect of thymoquinone and/or bee pollen on fluvastatin-induced hepatitis in rats
por: Amro E. Mohamed, et al.
Publicado: (2021)

Therapeutic Potential of Mitophagy-Inducing Microflora Metabolite, Urolithin A for Alzheimer’s Disease
por: Dona Pamoda W. Jayatunga, et al.
Publicado: (2021)

Sleep disturbances in Parkinson&#39;s disease patients and management options
por: Claassen DO, et al.
Publicado: (2011)

An update on the toxicity of A&beta; in Alzheimer&rsquo;s disease
por: J&uuml;rgen G&ouml;tz, et al.
Publicado: (2008)

Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies
por: Urrestarazu E, et al.
Publicado: (2016)

Alzheimer's disease and its treatment costs: case study in the Czech Republic
por: Mohelska H, et al.
Publicado: (2015)

Formulation optimization of galantamine hydrobromide loaded gel drug reservoirs in transdermal patch for Alzheimer’s disease
por: Woo FY, et al.
Publicado: (2015)

Potential Therapeutic Role of Osteopontin Inhibition in Liver Fibrosis -Induced by Thioacetamide in Rats
por: Ramadan A., et al.
Publicado: (2017)